GlassScriptPhysician profile
Jill Maxwell Sullivan
NPI 1174818355
$12,399.19
in general payments reported to CMS, 2019-2025
74 companies · $2,617 in 2025
The $2,617 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,106 · 2020: $549 · 2021: $11.92 · 2022: $2,034 · 2023: $2,154 · 2024: $2,928 · 2025: $2,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,522 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,522.27 |
| Education | $177.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,390.29 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $731.67 | 2019-2025 | Enhertu, Calquence, Tagrisso |
| E.R. Squibb & Sons, L.L.C. | $689.12 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Takeda Pharmaceuticals U.S.A., INC. | $636.23 | 2019-2025 | Alunbrig, Fruzaqla, Iclusig |
| Janssen Biotech, INC. | $581.91 | 2019-2025 | Tecvayli, Darzalex, Erleada |
| Merck Sharp & Dohme LLC | $576.31 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $486.68 | 2019-2025 | |
| Astellas Pharma US INC | $448.39 | 2019-2025 | Xtandi, Xospata, Padcev |
| Incyte Corporation | $440.77 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Celgene Corporation | $389.62 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Daiichi Sankyo INC. | $291.42 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Eisai INC. | $260.87 | 2019-2025 | |
| Heron Therapeutics, INC. | $253.63 | 2022 | |
| Abbvie INC. | $230.64 | 2022-2025 | Venclexta |
| Lilly USA, LLC | $228.64 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $199.78 | 2019-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $191.09 | 2022-2025 | Zejula, Jemperli, Ojjaara |
| Eagle Pharmaceuticals, INC. | $187.24 | 2022-2024 | |
| Seagen INC. | $177.46 | 2019-2023 | Adcetris, Tukysa |
| Jazz Pharmaceuticals INC. | $166.84 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.11 | 2019-2024 | |
| Genentech USA, INC. | $155.76 | 2019-2024 | Venclexta, Lunsumio, Polivy |
| Emd Serono, INC. | $155.72 | 2022-2025 | Bavencio |
| Octapharma USA, INC. | $151.98 | 2022 | |
| Janssen Scientific Affairs, LLC | $149.99 | 2022-2024 | Rybrevant |
| Amgen INC. | $146.58 | 2019 | |
| Rigel Pharmaceuticals, INC. | $140.57 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Genzyme Corporation | $140.12 | 2022-2025 | |
| Puma Biotechnology, INC. | $135.96 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $123.77 | 2022-2025 | Onivyde, Somatuline Depot, Tazverik |
| Array Biopharma INC | $122.39 | 2023-2025 | Mektovi, Braftovi, Lorbrena |
| Novocure INC. | $116.25 | 2020 | |
| Foundation Medicine, INC. | $114.67 | 2020 | |
| Karyopharm Therapeutics INC. | $112.72 | 2022-2025 | Xpovio |
| Taiho Oncology, INC. | $108.94 | 2019-2024 | |
| Aveo Pharmaceuticals, INC. | $108.77 | 2023-2025 | Fotivda |
| Spectrum Pharmaceuticals INC. | $106.04 | 2023-2025 | Rolvedon |
| Alexion Pharmaceuticals, INC. | $103.08 | 2022-2024 | Ultomiris |
| Exelixis INC. | $92.92 | 2023-2025 | Cabometyx |
| Adc Therapeutics America, INC. | $92.71 | 2022-2025 | |
| Genmab U.S., INC. | $90.59 | 2022-2025 | Epkinly, Tivdak |
| Janssen Pharmaceuticals, INC | $79.65 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.20 | 2019-2025 | |
| Kyowa Kirin, INC. | $69.40 | 2019-2024 | Poteligeo |
| Regeneron Healthcare Solutions, INC. | $63.30 | 2022-2025 | Libtayo |
| Sumitomo Pharma America, INC. | $63.06 | 2023-2025 | Orgovyx |
| Beone Medicines USA, INC. | $60.07 | 2025 | Brukinsa, Tevimbra |
| Tersera Therapeutics LLC | $52.92 | 2019-2025 | Zoladex |
| Deciphera Pharmaceuticals INC. | $49.26 | 2022-2023 | Qinlock |
| Beigene USA, INC. | $46.87 | 2022-2024 | Brukinsa |
| Clovis Oncology, INC. | $46.62 | 2019 | |
| Servier Pharmaceuticals LLC | $45.31 | 2022-2023 | |
| Immunocore Limited | $44.84 | 2024-2025 | Kimmtrak |
| Mirati Therapeutics, INC. | $42.60 | 2023-2024 | Krazati |
| Pharmacyclics LLC, An Abbvie Company | $38.06 | 2019-2022 | |
| Sobi, INC | $33.78 | 2023-2025 | |
| Cti Biopharma Corp. | $33.78 | 2022-2023 | Vonjo |
| Immunogen, INC. | $31.49 | 2023 | Elahere |
| Morphosys, US INC. | $29.38 | 2022-2023 | Monjuvi |
| Macrogenics, INC. | $28.75 | 2023 | |
| Helsinn Therapeutics (U.S.), INC. | $26.28 | 2019-2022 | |
| Genentech, INC. | $25.79 | 2024 | Columvi, Lunsumio |
| Blueprint Medicines Corporation | $25.60 | 2022-2023 | Ayvakit |
| Pharmaessentia USA Corporation | $24.87 | 2024 | Besremi |
| Geron Corporation | $23.62 | 2025 | Rytelo |
| Agios Pharmaceuticals, INC. | $23.26 | 2019-2020 | |
| Verastem, INC. | $19.77 | 2025 | Avmapki Fakzynja Co-Pack |
| Epizyme, INC. | $17.28 | 2022 | |
| Myovant Sciences INC. | $17.19 | 2022 | |
| Pharmacosmos Therapeutics INC. | $14.79 | 2023 | Monoferric |
| Springworks Therapeutics, INC. | $14.18 | 2024 | Ogsiveo |
| Dova Pharmaceuticals | $12.81 | 2020 | |
| Aurobindo Pharma USA, INC. | $12.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
Kisqali $337Enhertu $271Keytruda $260Xtandi $223Reblozyl $203Tukysa $197Tecvayli $192Scemblix $184Pemfexy $174Opdivo $171Lutathera $165Piqray $162Ibrance $161Darzalex $154Rezlidhia $141Tavalisse $141Opdualag $133Jakafi $129Elahere $124Mektovi $122Zepzelca $121Jaypirca $120Verzenio $120Orgovyx $119Alunbrig $118Venclexta $118Adcetris $117Lenvima $113Sarclisa $112Calquence $109Braftovi $109Fotivda $109Fabhalta $107Rolvedon $106Erleada $106Padcev $103Fruzaqla $103Onivyde $101Trodelvy $98.80Xpovio $98.02Retevmo $95.97Cabometyx $92.92Monjuvi $89.15Ultomiris $85.27Rybrevant $84.82Jemperli $83.91Zejula $83.91Welireg $82.66Elrexfio $80.98Krazati $79.99Inlyta $74.82Injectafer $73.86Ojjaara $73.80Brukinsa $72.17Lorbrena $67.34Xospata $65.60Xarelto $63.53Somatuline Depot $62.88Lunsumio $62.31Talvey $61.71Nubeqa $60.85Xofigo $60.85Gavreto $59.96Niktimvo $59.92Iclusig $59.22Talzenna $56.22Balversa $53.45Bavencio $52.95Lynparza $52.62Pemazyre $52.32Libtayo $48.03Paxlovid $47.20Zynlonta $46.56Kimmtrak $44.84Imbruvica $40.97Vonjo $40.70Polivy $36.52Epkinly $35.97Comirnaty $35.50Xalkori $35.13Inqovi $34.49Lonsurf $34.49Exkivity $34.29Pomalyst $32.32Nerlynx $31.95Promacta $31.94Poteligeo $31.84Ninlaro $30.43Besponsa $30.42Bosulif $30.42Tivdak $29.06Margenza $28.75Tagrisso $28.43Datroway $26.63Columvi $25.79Qinlock $25.72Besremi $24.87Zoladex $24.14Stivarga $23.83Vitrakvi $23.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.